Metraipolis › archive › dc_7e8ca35bb5cf

Characteristics and Clinical Outcomes of BRCA Germline Mutation Carriers with Advanced Breast Cancer Treated with PARP (Poly ADP-Ribose Polymerase)… — Europe PMC PMID:42073582

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42073582
DOI: 10.3390/cancers18081258
License (as archived): solo-consultazione
Archived: 2026-10-08T16:05:55.736Z
SHA-256 of the archived text: 8454ee488075a81fe74d93d72215db82ab6cf490a1a80a86eb681ac8cdefab73
Stable URL of this page: https://metraipolis.com/documento/dc_7e8ca35bb5cf

How to cite

Characteristics and Clinical Outcomes of BRCA Germline Mutation Carriers with Advanced Breast Cancer Treated with PARP (Poly ADP-Ribose Polymerase)… — Europe PMC PMID:42073582 — Europe PMC (en), https://europepmc.org/article/MED/42073582 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e8ca35bb5cf (Metraipolis archive dc_7e8ca35bb5cf, sha256 8454ee488075a81fe74d93d72215db82ab6cf490a1a80a86eb681ac8cdefab73)

BibTeX

@misc{dc7e8ca35bb5cf,
  title = {Characteristics and Clinical Outcomes of BRCA Germline Mutation Carriers with Advanced Breast Cancer Treated with PARP (Poly ADP-Ribose Polymerase)… — Europe PMC PMID:42073582},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42073582},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e8ca35bb5cf; sha256 8454ee488075a81fe74d93d72215db82ab6cf490a1a80a86eb681ac8cdefab73},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42073582. Agents can read the archived copy with the MCP tool read_document.